M&A Deal Summary |
|
|---|---|
| Date | 2006-06-26 |
| Target | Pfizer Consumer Healthcare |
| Sector | Life Science |
| Buyer(s) | Johnson & Johnson |
| Sellers(s) | Pfizer |
| Deal Type | Divestiture |
| Deal Value | 16.6B USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1886 |
| Sector | Consumer Products |
| Employees | 141,700 |
| Revenue | 93.8B USD (2021) |
Johnson & Johnson is a multinational medical devices, pharmaceutical and consumer packaged goods manufacturer. Johnson & Johnson was formed in 1886 and is based in New Brunswick, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 16 of 41 |
| Sector (Life Science) | 4 of 15 |
| Type (Divestiture) | 3 of 4 |
| Country (Germany) | 1 of 1 |
| Year (2006) | 2 of 3 |
| Size (of disclosed) | 4 of 26 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-02-02 |
FMS Future Medical System S.A.
Geneva, Switzerland FMS Future Medical System S.A. manufactures and markets arthroscopic fluid management systems. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-11-16 |
Conor Medsystems
Menlo Park, California, United States Conor Medsystems, Inc.developed stents and other medical devices as platforms for controlled local and systemic delivery of a wide variety of therapeutic agents. The Company's initial focus was on drug-eluting stents for the treatment of restenosis and vascular disease. |
Buy | $1.4B |
| Category | Company |
|---|---|
| Founded | 1849 |
| Sector | Life Science |
| Employees | 79,000 |
| Revenue | 81.3B USD (2021) |
Pfizer is a research-based, global biopharmaceutical company. Pfizer applies science and global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development and manufacture of healthcare products. The Company's global portfolio includes medicines, vaccines and medical devices, as well as many of the world’s best-known consumer healthcare products. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. The majority of Pfizer's revenues come from the manufacture and sale of biopharmaceutical products. Pfizer was founded in 1849 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 17 |
| Sector (Life Science) | 2 of 12 |
| Type (Divestiture) | 5 of 15 |
| Country (Germany) | 2 of 2 |
| Year (2006) | 1 of 1 |
| Size (of disclosed) | 1 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-04-06 |
Rinat Neuroscience
Palo Alto, California, United States Rinat Neuroscience Corp. a biotechnology company that is developing therapeutic proteins for the treatment of diseases and disorders of the central nervous system. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-02-09 |
BioRexis Pharmaceuticals
King of Prussia, Pennsylvania, United States BioRexis Pharmaceuticals Corp. is a bio-pharmaceutical company produces biopharmaceuticals. |
Buy | - |
